T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
JD.com
JD
$43.1B
| $308M | 0.07% |
14,490,471
-2,502,711
| -15% | -$60.4M |
|
|
PSB
302
DELISTED
PS Business Parks, Inc.
PSB
| $304M | 0.06% |
2,867,105
-65,749
| -2% | -$6.58M |
|
303
Atmos Energy
ATO
$28.6B
| $302M | 0.06% |
3,711,220
-107,338
| -3% | -$7.96M |
|
304
C.H. Robinson
CHRW
$17B
| $301M | 0.06% |
4,057,346
+274,055
| +7% | +$20M |
|
|
OPLN
305
Openlane
OPLN
$4.48B
| $301M | 0.06% |
19,049,407
+3,897,592
| +26% | +$58.3M |
|
|
XEC
306
DELISTED
CIMAREX ENERGY CO
XEC
| $300M | 0.06% |
2,513,208
-212,185
| -8% | -$23.8M |
|
307
First Horizon
FHN
$12B
| $298M | 0.06% |
21,631,557
-281,079
| -1% | -$3.89M |
|
|
GRFS
308
Grifois
GRFS
$5.44B
| $297M | 0.06% |
17,790,762
+4,651,357
| +35% | +$73.1M |
|
309
PNC Financial Services
PNC
$101B
| $296M | 0.06% |
3,633,618
-13,920
| -0.4% | -$1.2M |
|
310
ONE Gas
OGS
$5B
| $295M | 0.06% |
4,423,927
+7,705
| +0.2% | +$464K |
|
311
Kimco Realty
KIM
$16.1B
| $294M | 0.06% |
9,372,317
+290,230
| +3% | +$8.36M |
|
312
Oracle
ORCL
$419B
| $291M | 0.06% |
7,121,833
-249,339
| -3% | -$9.96M |
|
313
General Motors
GM
$78.4B
| $289M | 0.06% |
10,224,389
-3,100,690
| -23% | -$94.1M |
|
|
CORE
314
DELISTED
Core Mark Holding Co., Inc.
CORE
| $289M | 0.06% |
6,167,506
-214,400
| -3% | -$9.09M |
|
315
DaVita
DVA
$11.4B
| $288M | 0.06% |
3,730,231
-1,057,385
| -22% | -$79.9M |
|
|
K
316
DELISTED
Kellanova
K
| $285M | 0.06% |
3,721,991
-2,396,351
| -39% | -$172M |
|
317
Flowers Foods
FLO
$1.52B
| $285M | 0.06% |
15,213,497
-31,656
| -0.2% | -$589K |
|
318
Kraft Heinz
KHC
$29.2B
| $284M | 0.06% |
3,212,679
+361,208
| +13% | +$29.7M |
|
319
Mercado Libre
MELI
$98.4B
| $284M | 0.06% |
2,018,580
+89,710
| +5% | +$11.7M |
|
|
VER
320
DELISTED
VEREIT, Inc.
VER
| $282M | 0.06% |
5,554,431
+5,488,428
| +8,315% | +$259M |
|
321
Jones Lang LaSalle
JLL
$16.7B
| $281M | 0.06% |
2,881,465
+20,658
| +0.7% | +$2.37M |
|
322
Sprouts Farmers Market
SFM
$7.87B
| $278M | 0.06% |
12,152,314
-1,200,559
| -9% | -$30.7M |
|
323
Constellation Brands
STZ
$22.9B
| $276M | 0.06% |
1,667,625
-331,159
| -17% | -$51.8M |
|
|
TXNM
324
TXNM Energy Inc
TXNM
$5.91B
| $276M | 0.06% |
7,777,177
-97,590
| -1% | -$3.21M |
|
|
ACC
325
DELISTED
American Campus Communities, Inc.
ACC
| $276M | 0.06% |
5,212,102
-139,644
| -3% | -$6.56M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.